ANP32E drives vulnerability to ATR inhibitors by inducing R-loops-dependent transcription replication conflicts in triple negative breast cancer. - Lago S; Poli V; Fol L; Botteon M; Busi F; Turdo A; Gaggianesi M; Ciani Y; D'Amato G; Fagnocchi L; Fasciani A; Demichelis F; et al. (Nature communications, 2025)